As of April 1, 2018, it is possible for all pregnant women to opt for the NIPT. The acronym NIPT stands for Non-Invasive Prenatal Test. In this test, a sample of blood is taken to investigate whether the unborn fetus possibly has Down’s, Edwards’ or Patau’s syndrome. In the Netherlands, this is only possible within the TRIDENT-2 study.
The NIPT is available starting at 11 weeks of pregnancy. If you opt for the NIPT, you are participating in the TRIDENT-2 study and will be required to sign a consent form.
You will pay 175 euros for the NIPT in TRIDENT-2. This is not covered by the basic health insurance and/or supplementary health insurance.
For more information about the test, the research, and the syndromes under investigation, please visit this website.